| For: | Hsu PI, Lo GH, Lo CC, Lin CK, Chan HH, Wu CJ, Shie CB, Tsai PM, Wu DC, Wang WM, Lai KH. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 2004; 10(24): 3666-3669 [PMID: 15534928 DOI: 10.3748/wjg.v10.i24.3666] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i24/3666.htm |
| Number | Citing Articles |
| 1 |
Kenneth R DeVault. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations. Expert Review of Gastroenterology & Hepatology 2007; 1(2) doi: 10.1586/17474124.1.2.197
|
| 2 |
Grigoris I. Leontiadis, Virender K. Sharma, Colin W. Howden. Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials. Mayo Clinic Proceedings 2007; 82(3) doi: 10.1016/S0025-6196(11)61024-0
|
| 3 |
Alan N. Barkun, Marc Bardou, Ernst J. Kuipers, Joseph Sung, Richard H. Hunt, Myriam Martel, Paul Sinclair. International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. Annals of Internal Medicine 2010; 152(2) doi: 10.7326/0003-4819-152-2-201001190-00009
|
| 4 |
C. VAN RENSBURG, A. N. BARKUN, I. RACZ, R. FEDORAK, P. C. BORNMAN, C. BEGLINGER, J. BALANZÓ, J. DEVIÈRE, L. KUPCINSKAS, R. LUEHMANN, H. DOERFLER, S. SCHÄFER‐PREUSS. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Alimentary Pharmacology & Therapeutics 2009; 29(5) doi: 10.1111/j.1365-2036.2008.03904.x
|
| 5 |
Grigoris I. Leontiadis, Virender K. Sharma, Colin W. Howden. Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials. Mayo Clinic Proceedings 2007; 82(3) doi: 10.4065/82.3.286
|
| 6 |
Donna Chui, Flora Young, Aaron M. Tejani, Edward C. Dillon. Impact of Academic Detailing on Proton Pump Inhibitor Prescribing Behaviour in a Community Hospital. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 2011; 144(2) doi: 10.3821/1913-701X-144.2.66
|
| 7 |
M. SIMON‐RUDLER, J. MASSARD, B. BERNARD‐CHABERT, V. DI MARTINO, V. RATZIU, T. POYNARD, D. THABUT. Continuous infusion of high‐dose omeprazole is more effective than standard‐dose omeprazole in patients with high‐risk peptic ulcer bleeding: a retrospective study. Alimentary Pharmacology & Therapeutics 2007; 25(8) doi: 10.1111/j.1365-2036.2007.03286.x
|
| 8 |
Javier P. Gisbert. Tratamiento farmacológico de la hemorragia digestiva por úlcera péptica. Medicina Clínica 2006; 127(2) doi: 10.1157/13089992
|
| 9 |
K. Herrlinger. Einteilung und Management der oberen gastrointestinalen Blutung. Der Internist 2010; 51(9) doi: 10.1007/s00108-010-2590-9
|
| 10 |
Kevin A. Ghassemi, Thomas O. G. Kovacs, Dennis M. Jensen. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Current Gastroenterology Reports 2009; 11(6) doi: 10.1007/s11894-009-0071-x
|
| 11 |
Thomas O. G. Kovacs. Management of upper gastrointestinal bleeding. Current Gastroenterology Reports 2008; 10(6) doi: 10.1007/s11894-008-0099-3
|
| 12 |
Yen-I. Chen, Yidan Lu, Hisham Aldahab, Alan Barkun. GI Endoscopic Emergencies. 2016; doi: 10.1007/978-1-4939-3085-2_3
|
| 13 |
V. K. Vadgama, Y. A. Patel, T. K. Patel, C. B. Tripathi. Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction. Autonomic and Autacoid Pharmacology 2011; 31(1-2) doi: 10.1111/j.1474-8673.2011.00463.x
|
| 14 |
Panagiotis Tsibouris, Elias Zintzaras, Christos Lappas, Maria Moussia, George Tsianos, Theodoros Galeas, Spyros Potamianos. High-Dose Pantoprazole Continuous Infusion Is Superior to Somatostatin After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. The American Journal of Gastroenterology 2007; 102(6) doi: 10.1111/j.1572-0241.2007.01120.x
|
| 15 |
Thomas O G Kovacs, Dennis M Jensen. The Short-Term Medical Management of Non-Variceal Upper Gastrointestinal Bleeding. Drugs 2008; 68(15) doi: 10.2165/00003495-200868150-00003
|
| 16 |
Loren Laine, Kenneth R. McQuaid. Endoscopic Therapy for Bleeding Ulcers: An Evidence-Based Approach Based on Meta-Analyses of Randomized Controlled Trials. Clinical Gastroenterology and Hepatology 2009; 7(1) doi: 10.1016/j.cgh.2008.08.016
|
| 17 |
Antonio Garrido, María Isabel Iborra, Esteban Saperas, Mónica de Sousa. Prevalencia de nueva hemorragia por úlcera péptica en pacientes tratados con inhibidores de la bomba de protones por vía intravenosa. Medicina Clínica 2010; 134(13) doi: 10.1016/j.medcli.2009.11.038
|
| 18 |
Keith M. Olsen. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding. American Journal of Health-System Pharmacy 2005; 62(10_Supplement_2) doi: 10.1093/ajhp/62.10_Supplement_2.S18
|
| 19 |
Ying-Shi Zhang, Qing Li, Bo-Sai He, Ran Liu, Zuo-Jing Li. Proton pump inhibitors therapy <italic>vs</italic> H<sub>2</sub> receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis. World Journal of Gastroenterology 2015; 21(20): 6341-6351 doi: 10.3748/wjg.v21.i20.6341
|
| 20 |
Dennis M Jensen, Samuel C Pace, Elaine Soffer, Gail M Comer. Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study. The American Journal of Gastroenterology 2006; 101(9) doi: 10.1111/j.1572-0241.2006.00773.x
|
| 21 |
Hisham AL Dhahab, Alan Barkun. The Acute Management of Nonvariceal Upper Gastrointestinal Bleeding. Ulcers 2012; 2012 doi: 10.1155/2012/361425
|
| 22 |
John W Devlin, Lynda S Welage, Keith M Olsen. Proton Pump Inhibitor Formulary Considerations in the Acutely Ill Part 2: Clinical Efficacy, Safety, and Economics. Annals of Pharmacotherapy 2005; 39(11) doi: 10.1345/aph.1G176
|
| 23 |
|
| 24 |
Kirill Rivkin, Aleksandr Lyakhovetskiy. Treatment of nonvariceal upper gastrointestinal bleeding. American Journal of Health-System Pharmacy 2005; 62(11) doi: 10.1093/ajhp/62.11.1159
|
| 25 |
Hwai-Jeng Lin, Wen-Ching Lo, Yang-Chih Cheng, Chin-Lin Perng. Role of Intravenous Omeprazole in Patients with High-Risk Peptic Ulcer Bleeding After Successful Endoscopic Epinephrine Injection: A Prospective Randomized Comparative Trial. The American Journal of Gastroenterology 2006; 101(3) doi: 10.1111/j.1572-0241.2006.00399.x
|
| 26 |
Iyad Khamaysi, Ian M. Gralnek. THE EFFICACY OF INTRAVENOUS PROTON PUMP INHIBITORS (IV PPI) AFTER ENDOSCOPIC EPINEPHRINE INJECTION IN PATIENTS WITH HIGH-RISK PEPTIC ULCER BLEEDING. Evidence-Based Gastroenterology 2007; 8(1) doi: 10.1097/EBG.0b013e318031dfb6
|
| 27 |
Stephen W Nissen, Keith M Olsen. Selection of Proton Pump Inhibitors for Formulary Inclusion. Disease Management & Health Outcomes 2007; 15(5) doi: 10.2165/00115677-200715050-00003
|
| 28 |
Eduardo A. Rodriguez, Elie Donath, Akbar K. Waljee, Daniel A. Sussman. Value of Oral Proton Pump Inhibitors in Acute, Nonvariceal Upper Gastrointestinal Bleeding. Journal of Clinical Gastroenterology 2017; 51(8) doi: 10.1097/MCG.0000000000000625
|
| 29 |
Mohamed H. Emara, Ehab M. Darwiesh, Ahmed S. Bihery, Tarik I. Zaher. Endoscopic injection of autologous blood versus diluted epinephrine for control of actively bleeding gastroduodenal ulcers. European Journal of Gastroenterology & Hepatology 2014; 26(11) doi: 10.1097/MEG.0000000000000180
|
| 30 |
Christo J. Van Rensburg, Susan Cheer. Pantoprazole for the Treatment of Peptic Ulcer Bleeding and Prevention of Rebleeding. Clinical Medicine Insights: Gastroenterology 2012; 5 doi: 10.4137/CGast.S9893
|
| 31 |
Insung Kim, Yoon-Seon Lee, Byuk Sung Koh, Won Kim, Kyoung Soo Lim. Does Adding Somatostatin to Proton Pump Inhibitor Improve the Outcome of Peptic Ulcer Bleeding?. The Korean Journal of Critical Care Medicine 2008; 23(2) doi: 10.4266/kjccm.2008.23.2.75
|
| 32 |
Grigorios I. Leontiadis, Colin W. Howden. The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Bleeding. Gastroenterology Clinics of North America 2009; 38(2) doi: 10.1016/j.gtc.2009.03.008
|